Comparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registry

OBJECTIVES: To characterise the comparative effectiveness of combination therapy (a tumour necrosis factor inhibitor (TNFi) and a conventional synthetic disease-modifying antirheumatic drug (csDMARD) such as methotrexate) and monotherapy (TNFi only) for psoriatic arthritis (PsA) from a large US regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip J, Collier, David H, Saunders, Katherine C, Li, Guo, Kremer, Joel M, Greenberg, Jeffrey D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716450/
https://www.ncbi.nlm.nih.gov/pubmed/26819748
http://dx.doi.org/10.1136/rmdopen-2015-000181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716450/
https://www.ncbi.nlm.nih.gov/pubmed/26819748
http://dx.doi.org/10.1136/rmdopen-2015-000181

Ejemplares similares